ProSciento, Inc.
ProSciento is a leading clinical research organization dedicated to advancing metabolic disease therapeutics through science-driven services, innovative methodologies, and extensive expertise in obesity, diabetes, NASH, and related conditions. With over 20 years of experience, they focus on clinical trial design, patient engagement, regulatory affairs, and specialized methodologies to support global drug development and improve patient outcomes.
Industries
Nr. of Employees
medium (51-250)
Products
Diagnostic patient registry and recruitment platform
Registry and dataset used to identify eligible patients, analyze recruitment trends and support site selection and enrollment optimization for metabolic clinical trials.
Clinical Research Unit (CRU) facility
Specialized inpatient/outpatient research facility with extended-stay capability, 24/7 clinical teams, CLIA lab access and USP 797/800 clean-room support for complex metabolic studies.
Publication library of metabolic clinical research
Curated collection of fact sheets, articles, posters and webinars documenting clinical methods, study results and translational research in obesity, diabetes and steatotic liver disease.
Investigator registry
A global registry of investigators, clinical trial sites and specialized method hubs to support site selection and investigator engagement across multiple regions.
Diagnostic patient registry and recruitment platform
Registry and dataset used to identify eligible patients, analyze recruitment trends and support site selection and enrollment optimization for metabolic clinical trials.
Clinical Research Unit (CRU) facility
Specialized inpatient/outpatient research facility with extended-stay capability, 24/7 clinical teams, CLIA lab access and USP 797/800 clean-room support for complex metabolic studies.
Publication library of metabolic clinical research
Curated collection of fact sheets, articles, posters and webinars documenting clinical methods, study results and translational research in obesity, diabetes and steatotic liver disease.
Investigator registry
A global registry of investigators, clinical trial sites and specialized method hubs to support site selection and investigator engagement across multiple regions.
Services
Strategic clinical development planning including target product profiles, development plans, regulatory readiness assessments and program-specific scientific/project management for metabolic therapeutics and devices.
Protocol writing, inclusion/exclusion modeling, endpoint selection and study optimization for first-in-human through later-stage metabolic trials.
Assessment of IND readiness, regulatory strategy development, document preparation, submission management and agency meeting support.
Patient-centric recruitment and retention programs using diagnostic registries, targeted outreach, automated communications and concierge services to improve enrollment and retention.
Global site identification and vendor coordination using an investigator registry and diagnostic data to select sites with eligible patient populations and streamline vendor activities.
On-site and centralized clinical monitoring and physician medical monitoring with integrated safety oversight and risk mitigation strategies for protocol compliance and patient safety.
Strategic clinical development planning including target product profiles, development plans, regulatory readiness assessments and program-specific scientific/project management for metabolic therapeutics and devices.
Protocol writing, inclusion/exclusion modeling, endpoint selection and study optimization for first-in-human through later-stage metabolic trials.
Assessment of IND readiness, regulatory strategy development, document preparation, submission management and agency meeting support.
Patient-centric recruitment and retention programs using diagnostic registries, targeted outreach, automated communications and concierge services to improve enrollment and retention.
Global site identification and vendor coordination using an investigator registry and diagnostic data to select sites with eligible patient populations and streamline vendor activities.
On-site and centralized clinical monitoring and physician medical monitoring with integrated safety oversight and risk mitigation strategies for protocol compliance and patient safety.
Expertise Areas
- Clinical trial management for metabolic indications
- Clinical pharmacology and early-phase metabolic studies
- Patient recruitment and registry-driven enrollment
- Biomarker development and translational research
Key Technologies
- Automated glucose clamp systems
- Stable isotope tracer techniques
- Magnetic resonance imaging–based liver fat quantification (MRI-PDFF)
- Indirect calorimetry